Showing results (101-110 of 225) with videos related to
Sort By:
Pageof 23
Cancer Treatment Reviews|August 20, 2018
De novo metastatic castration sensitive prostate cancer: State of art and future perspectivesClaudia Mosillo, Roberto Iacovelli, Chiara Ciccarese, et al.Cancer Treatment Reviews|February 15, 2024
Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectivesMatteo Bauckneht, Chiara Ciccarese, Riccardo Laudicella, et al.Journal of Clinical Pathology|June 13, 2020
Methylation study of the Paris system for reporting urinary (TPS) categoriesFrancesco Pierconti, Maurizio Martini, Tonia Cenci, et al.European Journal of Cancer (Oxford, England : 1990)|July 31, 2017
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapiesChiara Ciccarese, Roberto Iacovelli, Matteo Brunelli, et al.Cancer Treatment Reviews|March 15, 2016
Metabolic phenotype of bladder cancerFrancesco Massari, Chiara Ciccarese, Matteo Santoni, et al.Targeted Oncology|October 3, 2015
Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-AnalysisRoberto Iacovelli, Franco Nolè, Elena Verri, et al.Anticancer Research|December 31, 2021
The Role of Fast and Deep PSA Response in Castration-sensitive Prostate CancerRoberto Iacovelli, Chiara Ciccarese, Orazio Caffo, et al.Current Drug Metabolism|May 20, 2017
Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment?Chiara Ciccarese, Rodolfo Montironi, Michelangelo Fiorentino, et al.Seminars in Oncology|October 2, 2022
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysisLorenzo Belluomini, Sara Pilotto, Alice Avancini, et al.Journal of Neuro-Oncology|April 9, 2013
Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastomaMatteo Santoni, Silvia Scoccianti, Ivan Lolli, et al.Pageof 23